This paper evaluates claims about large macroeconomic implications of new advances in AI. It starts from a task-based model of AI’s effects, working through automation and task complementarities. So ...
The FDA approved the combination of relacorilant and nab-paclitaxel in platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. The FDA has approved relacorilant (Lifyorli) plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results